Skip to main content
CMPS logo

CMPS · COMPASS Pathways plc · Financials

Track CMPS — free
$8.59 +0.18 (+2.14%) At close · Nov 3 Q2 2026 earnings call transcript
Market Cap
$1.16B
Shares
138.48M
Volume · Nov 3 8.8M Avg daily vol (3M) 2.97M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Net Income
-$287.86M -85.6%
FY2025 Net Income FY2019–FY2025
Diluted EPS
-$3.08 -33.9%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
-$157.24M -31.9%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$109.02M $118.44M $119.04M $87.52M $65.05M $44.03M $23.37M $12.56M
— $60.6M $59.17M $49.4M $45.35M $39.19M $28.03M $8.62M
— — — $242K $330K $175K $112K $63K
$197.67M $179.04M $178.21M $136.92M $110.4M $83.22M $51.39M $21.18M
-$197.67M -$179.04M -$178.21M -$136.92M -$110.4M -$83.22M -$51.39M -$21.18M
$5.59M $4.52M $4.48M $2.2M $0 $0 — —
$11.07M $7.18M $8.27M $4.62M — — — —
-$72.16M -$111.3M $24.68M $19.24M $19.31M $11.68M -$8.91M $1.58M
-$269.82M -$290.34M -$153.53M -$117.68M -$91.1M -$71.54M -$60.3M -$19.6M
-$3.52M -$2.47M $1.59M $780K $408K $199K $32K $15K
-$266.3M -$287.86M -$155.12M -$118.46M -$91.51M -$71.74M -$60.33M -$19.61M
— — — -$118.46M -$91.51M -$71.74M -$60.33M —
-$266.03M -$286.46M -$154.39M -$118.52M -$117.21M -$77.49M -$45.65M -$19.28M
USD/shares -$2.27 -$3.08 -$2.30 -$2.32 -$2.16 -$1.79 -$3.55 -$2.62
USD/shares -$3.48 -$3.08 -$2.30 -$2.32 -$2.16 -$1.79 -$3.55 -$2.62
shares — 93.5M 67.48M 51.03M 42.44M 40M 16.99M 7.48M
shares — 93.5M 67.48M 51.03M 42.44M 40M 16.99M 7.48M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current debt and lease obligations 2026-09-30 USD 1,425,000 10-Q filed 2026-11-03
Current operating lease liabilities 2026-09-30 USD 1,803,000 10-Q filed 2026-11-03
Long-term debt, including current maturities 2026-09-30 USD 50,986,000 10-Q filed 2026-11-03
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of long-term debt
USD 1,425,000
Noncurrent debt carrying amount
USD 49,561,000
Noncurrent operating lease liabilities 2026-09-30 USD 1,605,000 10-Q filed 2026-11-03
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 1.40×
EV/EBIT
—
Peer median 18.31×
P/E (TTM)
—
Peer median 23.36×

Peer medians compare against the 32 similar-size Medical Care Facilities companies (of 57 listed).

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023
Single Operating Segment -$179,037,000 -$178,205,000 -$136,919,000
Key facts CIK 1816590 CUSIP 20451W101 13F (30d) 77 filings 71 filers Visit website Investor relations